Related Experiment Videos
[Alpha 1-antitrypsin deficiency in childhood]
Revue Francaise De Transfusion Et Immuno-Hematologie
|December 1, 1985
Summary
Alpha-1-antitrypsin deficiency (PiZ allele) can cause neonatal cholestasis in infants. Many infants with this condition develop cirrhosis, portal hypertension, and some tragically die during childhood.
Area of Science:
- Biochemistry
- Genetics
- Hepatology
Context:
- Alpha-1-antitrypsin (AAT) is a crucial serum protease inhibitor.
- Genetic variations, particularly the PiZ allele, are linked to AAT deficiency.
- AAT deficiency affects multiple organs, notably the liver and lungs.
Purpose:
- To investigate the clinical course and prognostic indicators of neonatal cholestasis in infants with Alpha-1-antitrypsin deficiency (PiZZ genotype).
Summary:
- Eleven percent of PiZZ infants exhibit prolonged neonatal cholestasis.
- Among these, 25 out of 45 developed cirrhosis, with 19 presenting portal hypertension.
- Poor prognostic indicators include persistent jaundice, early splenomegaly, hepatomegaly, abnormal liver function, and early portal fibrosis.
Impact:
- Identifies severe outcomes in PiZZ infants with neonatal cholestasis, including cirrhosis and mortality.
- Highlights specific clinical and histological features associated with a poor prognosis.
- Informs early diagnosis and management strategies for AAT deficiency-related liver disease in neonates.